Latest Pulmonology Stories
Where You Live with Asthma Matters, Air Quality is Just One of Many Factors WASHINGTON, May 7, 2013 /PRNewswire-USNewswire/ -- There is still no cure for asthma, so for 22 million people in the U.S., this chronic disease continues to be a daily burden no matter where they live. But it's not just air pollution they should be worried about. Factors such as pollen, secondhand smoke - even high rates of poverty, a large uninsured population or a high number of ER visits - can be...
Exploring the latest innovations in healthcare. SOLNA, Sweden (PRWEB) May 06, 2013 Aerocrine AB announced today that their NIOX MINO® device will be featured in an upcoming episode of Health Heroes, set to air later this year via the Discovery Channel. Aerocrine is focused on improving the management and care of patients with inflammatory airway diseases, such as asthma. This segment of Health Heroes will focus on Aerocrine's NIOX MINO®, a point-of-care device designed to...
The site, which aims to celebrate and help educate families of asthma sufferers, launches on May 7th—World Asthma Day. Los Angeles, CA (PRWEB) May 06, 2013 LivingWithAsthma.net, the newest online support community for families of children with asthma, launches tomorrow, May 7, 2013, which is World Asthma Day—an annual event organized by the Global Initiative for Asthma (GINA). The new site seeks to raise awareness of the disease, offer practical lifestyle tips and advice for...
The American Thoracic Society has released new official clinical practice guidelines on the diagnosis and management of exercise-induced bronchoconstriction (EIB), the acute airway narrowing that occurs as a result of exercise. The guidelines appear in the May 1, 2013 American Journal of Respiratory and Critical Care Medicine. "While a large proportion of asthma patients experience exercise-induced respiratory symptoms, EIB also occurs frequently in subjects without asthma," said Jonathan...
WARRINGTON, Pa., May 1, 2013 /PRNewswire/ -- Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, today announced the release of two peer-reviewed publications related to AFECTAIR(®), the Company's proprietary aerosol-conducting airway connector designed with the goal of simplifying and improving aerosolized medication delivery to infants requiring mechanical ventilation in the...
CHEST JOURNAL TO PUBLISH ARTICLE FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION IN JULY ISSUE AND ONLINE NORTHBROOK, Ill., April 25, 2013 /PRNewswire-USNewswire/ -- An updated analysis from the Centers for Disease Control and Prevention (CDC) reports a decrease in deaths among male patients who have chronic obstructive pulmonary disease (COPD) and a decline in hospitalizations for patients with COPD. The report also reveals that rates of physician-based office and emergency...
Baylor College of Medicine researchers will lead a three-year, $4.2 million study funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to determine whether drugs called beta blockers can ease airway narrowing in patients with asthma and examine potential mechanisms. Researchers from Duke University in Durham, North Carolina, and Washington University in St. Louis, Missouri, also will participate. "Previously, beta...
LONDON and SOUTH SAN FRANCISCO, Calif., April 17, 2013 /PRNewswire/ -- GlaxoSmithKline plc (LSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the Pulmonary-Allergy Drugs Advisory Committee (PADAC) to the US Food and Drug Administration (FDA) voted that the efficacy and safety data provide substantial evidence to support approval of BREO(TM) ELLIPTA(TM) as a once-daily inhaled treatment for the long-term, maintenance treatment of airflow obstruction in patients with...
A new study looking at the genomes of more than 1,500 patients with idiopathic pulmonary fibrosis, a rare and devastating lung disease, found multiple genetic associations with the disease, including one gene variant that was linked to an increase in the risk of death. The study, released early online in The Lancet Respiratory Medicine, showed that a variant in a gene called TOLLIP was associated with an increased mortality risk. That variant resulted in decreased expression of TOLLIP in...
BRISBANE, Calif., April 17, 2013 /PRNewswire/ -- InterMune, Inc. (NASDAQ: ITMN) today announced that it will release its first quarter 2013 financial results at the close of the U.S. markets on Wednesday, April 24, 2013. A live conference call and webcast will be hosted by InterMune at 4:30 p.m. Eastern time that same day. (Logo: http://photos.prnewswire.com/prnh/20120827/SF62570LOGO) Interested investors and others may participate in the conference call by dialing 800-891-8257...
Latest Pulmonology Reference Libraries
Human parainfluenza viruses, belonging to the paramyxovirus family, are a group of four distinct serotypes of enveloped single-stranded RNA viruses. They are the second most common cause of lower respiratory tract infection in younger children. Many times the host has repeat infections throughout life with symptoms that may include upper respiratory tract illness or more commonly, a cold and sore throat. It can also cause severe pneumonia in immunosuppressed people. There is currently no...
